Stereotyped B cell receptors in B cell leukemias and lymphomas

Methods in Molecular Biology

Volumn 971, Issue , 2013, Pages 135-148

  Darzentas, Nikos ^a   Stamatopoulos, Kostas ^b,c  

^a MASARYK UNIVERSITY   (Czech Republic)

^b G PAPANICOLAOU HOSPITAL   (Greece)

^c INFORMATION TECHNOLOGIES INSTITUTE   (Greece)

Author keywords

Antigen; B cell receptor; Bioinformatics; CDR3; Immunoglobulin gene; Pattern; Stereotypy

Indexed keywords

B LYMPHOCYTE RECEPTOR; LYMPHOCYTE ANTIGEN RECEPTOR;

AMINO ACID SEQUENCE; ARTICLE; B CELL LEUKEMIA; HISTOPATHOLOGY; HUMAN; LYMPHOMA; PRIORITY JOURNAL; STEREOTYPY; B CELL LYMPHOMA; CHEMISTRY; IMMUNOLOGY; METABOLISM; REVIEW;

AMINO ACID SEQUENCE; HUMANS; LEUKEMIA, B-CELL; LYMPHOMA, B-CELL; RECEPTORS, ANTIGEN, B-CELL;

MLCS; MLOWN;

EID: 84878649009     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-62703-269-8_8     Document Type: Article

References (39)

1. Stevenson FK, Sahota SS, Ottensmeier CH, Zhu D, Forconi F, Hamblin TJ (2001) The occurrence and signi ficance of V gene mutations in B cell-derived human malignancy. Adv Cancer Res 83:81-116
2. Chiorazzi N, Ferrarini M (2003) B cell chronic lymphocytic leukemia: lessons learned from studies of the B cell antigen receptor. Annu Rev Immunol 21:841-894
3. Dunn-Walters D, Thiede C, Alpen B, Spencer J (2001) Somatic hypermutation and B-cell lymphoma. Philos Trans R Soc Lond B Biol Sci 356:73-82
4. Ghia P, Granziero L, Chilosi M, Caligaris-Cappio F (2002) Chronic B cell malignancies and bone marrow microenvironment. Semin Cancer Biol 12:149-155
5. O'Brien S, Burger J, Blum KA et al (2011) The Bruton's Tyrosine Kinase (BTK) inhibitor PCI-32765 induces durable responses in relapsed or refractory (R/R) chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL): follow-up of a phase Ib/II study. Blood 118 (Abstract 983)
6. Wang L, Martin P, Blum KA et al (2011) The Bruton's Tyrosine Kinase inhibitor PCI-32765 is highly active as single-agent therapy in previously-treated mantle cell lymphoma (MCL): preliminary results of a phase II trial. Blood 118 (Abstract 442)
7. Chiorazzi N, Ferrarini M (2011) Cellular origin(s) of chronic lymphocytic leukemia: cautionary notes and additional considerations and possibilities. Blood 117:1781-1791
8. Schroeder HW Jr, Dighiero G (1994) The pathogenesis of chronic lymphocytic leukemia: analysis of the antibody repertoire. Immunol Today 15:288-294
9. Fais F, Ghiotto F, Hashimoto S et al (1998) Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors. J Clin Invest 102:1515-1525
10. Stamatopoulos K, Belessi C, Hadzidimitriou A et al (2005) Immunoglobulin light chain repertoire in chronic lymphocytic leukemia. Blood 106:3575-3583
11. Damle RN, Wasil T, Fais F et al (1999) Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 94:1840-1847
12. Hamblin TJ, Davis Z, Gardiner A, Oscier DG, Stevenson FK (1999) Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 94:1848-1854
13. Ghia P, Stamatopoulos K, Belessi C et al (2007) European Research Initiative on CLL. ERIC recommendations on IGHV gene mutational status analysis in chronic lymphocytic leukemia. Leukemia 21:1-3
14. Langerak AW, Davi F, Ghia P et al (2011) European Research Initiative on CLL (ERIC). Immunoglobulin sequence analysis and prognostication in CLL: guidelines from the ERIC review board for reliable interpretation of problematic cases. Leukemia 25:979-984
15. Hashimoto S, Dono M, Wakai M et al (1995) Somatic diversi fication and selection of immunoglobulin heavy and light chain variable region genes in IgG+ CD5+ chronic lymphocytic leukemia B cells. J Exp Med 181:1507-1517
16. Efremov DG, Ivanovski M, Siljanovski N et al (1996) Restricted immunoglobulin VH region repertoire in chronic lymphocytic leukemia patients with autoimmune hemolytic anemia. Blood 87:3869-3876
17. Johnson TA, Rassenti LZ, Kipps TJ (1997) Ig VH1 genes expressed in B cell chronic lymphocytic leukemia exhibit distinctive molecular features. J Immunol 158:235-246
18. Widhopf GF 2nd, Kipps TJ (2001) Normal B cells express 51p1-encoded Ig heavy chains that are distinct from those expressed by chronic lymphocytic leukemia B cells. J Immunol 166:95-102
19. Tobin G, Thunberg U, Johnson A et al (2003) Chronic lymphocytic leukemias utilizing the VH3-21 gene display highly restricted Vlambda2-14 gene use and homologous CDR3s: implicating recognition of a common antigen epitope. Blood 101:4952-4957
20. Widhopf GF 2nd, Rassenti LZ, Toy TL, Gribben JG, Wierda WG, Kipps TJ (2004) Chronic lymphocytic leukemia B cells of more than 1% of patients express virtually identical immunoglobulins. Blood 104:2499-2504
21. Ghiotto F, Fais F, Valetto A et al (2004) Remarkably similar antigen receptors among a subset of patients with chronic lymphocytic leukemia. J Clin Invest 113:1008-1016
22. Messmer BT, Albesiano E, Efremov DG et al (2004) Multiple distinct sets of stereotyped antigen receptors indicate a role for antigen in promoting chronic lymphocytic leukemia. J Exp Med 200:519-525
23. Tobin G, Thunberg U, Karlsson K et al (2004) Subsets with restricted immunoglobulin gene rearrangement features indicate a role for antigen selection in the development of chronic lymphocytic leukemia. Blood 104:2879-2885
24. Stamatopoulos K, Belessi C, Moreno C et al (2007) Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: pathogenetic implications and clinical correlations. Blood 109:259-270
25. Murray F, Darzentas N, Hadzidimitriou A et al (2008) Stereotyped patterns of somatic hypermutation in subsets of patients with chronic lymphocytic leukemia: implications for the role of antigen selection in leukemogenesis. Blood 111:1524-1533
26. Bomben R, Dal Bo M, Capello D et al (2009) Molecular and clinical features of chronic lymphocytic leukaemia with stereotyped B cell receptors: results from an Italian multicentre study. Br J Haematol 144:492-506
27. Darzentas N, Hadzidimitriou A, Murray F et al (2010) A different ontogenesis for chronic lymphocytic leukemia cases carrying stereotyped antigen receptors: molecular and computational evidence. Leukemia 24:125-132
28. Hadzidimitriou A, Agathangelidis A, Darzentas N et al (2011) Is there a role for antigen selection in mantle cell lymphoma? Immunogenetic support from a series of 807 cases. Blood 118:3088-3095
29. Agathangelidis A, Hadzidimitriou A, Rosenquist R, Stamatopoulos K (2011) Unlocking the secrets of immunoglobulin receptors in mantle cell lymphoma: implications for the origin and selection of the malignant cells. Semin Cancer Biol 21:299-307
30. Bikos V, Darzentas N, Hadzidimitriou A et al (2012) Over 30% of patients with splenic marginal zone lymphoma express the same immunoglobulin heavy variable gene: ontogenetic implications. Leukemia. 26:1638-1646]
31. Zibellini S, Capello D, Forconi F et al (2010) Stereotyped patterns of B-cell receptor in splenic marginal zone lymphoma. Haematologica 95:1792-1796
32. Xu JL, Davis MM (2000) Diversity in the CDR3 region of V(H) is suf ficient for most antibody speci ficities. Immunity 13:37-45
33. Barrios Y, Jirholt P, Ohlin M (2004) Length of the antibody heavy chain complementarity determining region 3 as a speci ficity-determining factor. J Mol Recognit 17:332-338
34. Henikoff S, Henikoff JG (1993) Performance evaluation of amino acid substitution matrices. Proteins 17:49-61
35. Arvaniti E, Ntoufa S, Papakonstantinou N et al (2011) Toll-like receptor signaling pathway in chronic lymphocytic leukemia: distinct gene expression pro files of potential pathogenetic signi ficance in speci fic subsets of patients. Haematologica 96:1644-1652
36. Kirkham PM, Mortari F, Newton JA, Schroeder HW Jr (1992) Immunoglobulin VH clan and family identity predicts variable domain structure and may in fl uence antigen binding. EMBO J 11:603-609
37. Rigoutsos I, Floratos A (1998) Combinatorial pattern discovery in biological sequences: the TEIRESIAS algorithm. Bioinformatics 14: 55-67
38. Pommie C, Levadoux S, Sabatier R, Lefranc G, Lefranc MP (2004) IMGT standardized criteria for statistical analysis of immunoglobulin V-REGION amino acid properties. J Mol Recognit 17:17-32
39. Agathangelidis A, Darzentas N, Hadzidimitriou A et al (2012) Stereotyped B-cell receptors in one-third of chronic lymphocytic leukemia: a molecular classi fication with implications for targeted therapies. Blood 119:4467-4475